Australia markets closed

YPF Sociedad Anónima (YPF)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
19.24+0.17 (+0.87%)
As of 09:36AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 7.50B
Enterprise value 14.97B
Trailing P/E N/A
Forward P/E 4.49
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.44
Price/book (mrq)0.84
Enterprise value/revenue 0.88
Enterprise value/EBITDA 3.59

Trading information

Stock price history

Beta (5Y monthly) 1.68
52-week change 368.76%
S&P500 52-week change 321.23%
52-week high 322.27
52-week low 39.57
50-day moving average 318.74
200-day moving average 315.45

Share statistics

Avg vol (3-month) 32.42M
Avg vol (10-day) 32.4M
Shares outstanding 5393.31M
Implied shares outstanding 6498.7M
Float 8192.66M
% held by insiders 10.00%
% held by institutions 111.11%
Shares short (28 Mar 2024) 42.85M
Short ratio (28 Mar 2024) 41.06
Short % of float (28 Mar 2024) 4N/A
Short % of shares outstanding (28 Mar 2024) 40.71%
Shares short (prior month 29 Feb 2024) 41.66M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 40.73
Payout ratio 40.00%
Dividend date 318 July 2019
Ex-dividend date 409 July 2019
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -7.58%
Operating margin (ttm)7.33%

Management effectiveness

Return on assets (ttm)2.63%
Return on equity (ttm)-13.03%

Income statement

Revenue (ttm)17.31B
Revenue per share (ttm)44.19
Quarterly revenue growth (yoy)47.70%
Gross profit (ttm)N/A
EBITDA 4.12B
Net income avi to common (ttm)-1.31B
Diluted EPS (ttm)-3.35
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.39B
Total cash per share (mrq)3.53
Total debt (mrq)8.86B
Total debt/equity (mrq)97.85%
Current ratio (mrq)0.90
Book value per share (mrq)22.75

Cash flow statement

Operating cash flow (ttm)5.91B
Levered free cash flow (ttm)-1.49B